Pharmaceuticals solutions
Data Quality & Observability for Pharmaceuticals
Beryl Analytics's data quality & observability work for pharma & biotech starts with one question: what decision is this going to change? If we can't answer that in one sentence, we don't build the model. That discipline is why our engagements compound rather than gather dust.
Why pharmaceuticals teams choose Beryl Analytics for data quality & observability
- One slice, working, in six weeks. No 18-month roadmaps that quietly stall. The first data quality & observability slice is small, complete, and measurable inside the first sprint.
- Data contracts before models. We formalise the inputs your model depends on — schemas, freshness, ownership — so the system doesn't silently rot when an upstream team changes a field.
- Operator-grade UX. data quality & observability outputs render inside the tools your team already uses (your CRM, your ticketing system, your dashboards) — not yet another tab they have to remember.
- Right-sized stack. pharma & biotech don't need a Snowflake plus Databricks plus dbt cathedral to start. We pick the minimum infrastructure that ships value, then grow it deliberately.
- Outcome documentation. Every result is written up with the methodology, caveats, and ablation. Your CFO, auditor, and incoming team lead can all retrace why we built what we built.
How we deliver data quality & observability engagements
- 01
Discovery (week 1-2)
We meet your operators, map data sources, and pressure-test the business case. Half the value is sometimes in killing the wrong initiative and reframing the right one.
- 02
Pilot build (week 3-6)
One vertical slice end-to-end: ingest, model, dashboard, monitoring. Real data, real users, measurable result before we expand.
- 03
Productionise (week 7-12)
Hardening, governance, lineage, runbooks, observability. Pair-programmed with your team so they own it by handover.
- 04
Scale & evolve
Expansion into adjacent use cases, retraining cadence, model performance reviews, and a roadmap that compounds.
Frequently asked questions about Data Quality & Observability for Pharmaceuticals
How long does a typical Data Quality & Observability engagement take for a pharmaceuticals business?
Most data quality & observability projects for pharma & biotech land a working production slice within 4-6 weeks, then harden and expand over the following 8-12 weeks. Larger pharmaceuticals programmes that touch multiple business units take 4-6 months end-to-end.
What data do you need to start a Data Quality & Observability project in pharmaceuticals?
Minimum viable inputs are 12-18 months of historical transactional or operational data, basic entity reference tables, and access to the systems that will consume the output. We can work with messy data — cleaning is part of the engagement.
Can Beryl Analytics integrate data quality & observability with our existing pharma & biotech systems?
Yes. We're tool-agnostic and have integrated with Snowflake, BigQuery, Databricks, Salesforce, SAP, Oracle, custom in-house platforms, and dozens of pharmaceuticals-specific systems. Insights surface inside the tools your operators already use.
How do you measure success on a Data Quality & Observability engagement?
Before we model anything, we agree the business decision the output will change and the dollar metric we're targeting — revenue lifted, cost avoided, or risk reduced. Data Quality & Observability engagements in pharmaceuticals typically return 4-12x within the first year.
Do you work with pharmaceuticals businesses outside major NZ and AU cities?
Yes. We deliver remotely across New Zealand and Australia and visit on-site for discovery, key workshops, and go-live. Distance is not a blocker — many of our highest-impact data quality & observability engagements have been with regional pharma & biotech.